Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein

Nature Medicine

Volumn 3, Issue 3, 1997, Pages 341-345

  Rice, William G ^a   Turpin, Jim A ^a   Huang, Mingjun ^a   Clanton, David ^a   Buckheit Jr , Robert W ^b   Covell, David G ^a   Wallqvist, Anders ^a   Mcdonnell, Nazli B ^c   Deguzman, Roberto N ^c   Summers, Michael F ^c   Zalkow, Leon ^d   Bader, John P ^e   Haugwitz, Rudiger D ^e   Sausville, Edward A ^e  

^a SAIC FREDERICK INC   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZOFORMAMIDE; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; AZO COMPOUNDS; BINDING SITES; CAPSID; CAPSID PROTEINS; CELL LINE; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; VIRAL PROTEINS; VIRUS REPLICATION;

ADA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 16944362355     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0397-341     Document Type: Article

References (20)

1. Henderson, L.E., Copeland,T.D., Sowder, R.C., Smythers, G.W. & Oroszlan, S. Primary structure of the low molecular weight nucleic acid-binding proteins of murine leukemia viruses. J. Biol. Chem. 256, 8400-8406 (1981).
2. Berg, J.M. Potential metal-binding domains in nucleic acid binding proteins. Science 232, 485-487 (1986).
3. South, T.L. et al. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochem. 29, 7786-7789 (1990).
4. South, T.L. & Summers, M.F. Zinc fingers. Adv. Inorg. Biochem. Ser. 8, 199-248 (1990).
5. Darlix, J.-L., Vincent, A., Gabus, C., De Rocquigny, H. & Roques, B. Trans-activation of the 5′ to 3′ viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV-1 RNA. C. R. Acad. Sci. III 316, 763-771 (1993).
6. You, J.C. & McHenery, C.S. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269, 31491-31495 (1994).
7. Aldovini, A. & Young, R.A. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of non infectious virus. J. Virol. 64, 1920-1926 (1990).
8. Gorelick, R.J. et al. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: Replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. J. Virol. 70, 2593-2597 (1996).
9. Rice, W.G. et al. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 361, 473-475 (1993).
10. Rice, W.G. et al. The site of action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes. Proc. Natl. Acad. Sci. USA 90, 9721-9724 (1993).
11. Rice, W.G. et al. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270, 1194-1197 (1995).
12. Rice, W.G. & Turpin, J.A. Virus-encoded zinc fingers as targets for antiviral chemotherapy. Reviews Med. Virol. 6, 187-199 (1996).
13. Rice, W.G. et al. Inhibition of multiple phases of HIV-1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins. Antimicrob. Agents.Chemother. 41, 419-426 (1997).
14. Rice, W.G. et al. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 39, 3606-3616 (1996).
15. Turpin, J.A. et al. Reverse transcription of human immunodeficiency virus type 1 is blocked by retroviral zinc finger inhibitors. Antiviral. Chem. Chemother. 8, 60-69 (1997).
16. Turpin, J.A. et al. Inhibitors of HIV-1 zinc fingers prevent normal processing of Gag precursors and result in the release of noninfectious virus particles. J. Virol. 70, 6180-6189 (1996).
17. Vandevelde, M. et al. ADA, a potential anti-HIV drug. AIDS Res. Hum. Retro. 12, 567-568 (1996).
18. 113Cd NMR studies of a 1:1 Cd adduct with an 18-residue zinc finger peptide from HIV-1 nucleic acid binding protein, p7. J. Am. Chem. Soc. 111, 395-397 (1989).
19. Wallqvist, A. & Covell, D.G. Docking enzyme-inhibitor complexes using a preference based free-energy surface. Proteins 25, 403-419 (1996).
20. Bushman, F.D. & Craigie, R. Activities of human immunodeficiency virus (HIV) integration protein in vitro: Specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88, 1339-1343 (1991).